tadalafil has been researched along with Imidazosagatriazinone in 1 studies
Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (Imidazosagatriazinone) | Trials (Imidazosagatriazinone) | Recent Studies (post-2010) (Imidazosagatriazinone) |
---|---|---|---|---|---|
1,742 | 392 | 1,089 | 9 | 0 | 1 |
Protein | Taxonomy | tadalafil (IC50) | Imidazosagatriazinone (IC50) |
---|---|---|---|
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.0334 | |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | Homo sapiens (human) | 0.79 | |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Homo sapiens (human) | 0.79 | |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | 0.79 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antunes, JE; da Cunha, EF; Freitas, MP; Ramalho, TC; Rittner, R | 1 |
1 other study(ies) available for tadalafil and Imidazosagatriazinone
Article | Year |
---|---|
In silico prediction of novel phosphodiesterase type-5 inhibitors derived from Sildenafil, Vardenafil and Tadalafil.
Topics: Animals; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Imidazoles; Mice; Models, Molecular; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Quantitative Structure-Activity Relationship; Rats; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2008 |